Defendant

A and B shall be punished by imprisonment of one year and six months, by imprisonment of one year, and by imprisonment of six months, respectively.

Punishment of the crime

Defendant

B On July 8, 2020, the Seoul Central District Court sentenced 10 months of imprisonment with prison labor and 2 years of suspended execution for violating the Act on the Aggravated Punishment, etc. of Specific Crimes (Bodily Injury resulting from Dangerous Driving) and decided on July 16, 2020.

Defendant

A and Defendant B are those who jointly operate the LAF which mainly engages in trade business in Seongbuk-si, Sungnam-si, and Defendant C is a person who operates the packaging processing company in the trade name of “H” in Gwangju-si, and Defendant D is a person who operates the plastic packaging company in the trade name of “J” in Gwangju-si, Gwangju-si, with the trade name of “J” from “J”.

1. “Health Mack” in violation of the Pharmaceutical Affairs Act is textile products, rubber products, or similar products used for the purpose of treating, alleviating, treating, or preventing human or animal diseases, which are used for the purpose of protecting respiratory devices from hazardous harmful substances or infections, such as yellow dust, fine dust, etc., designated by the Minister of Food and Drug Safety (hereinafter “the Minister of Food and Drug Safety”), and “KF94 Eck” is a health mack that can lead to an average of at least 0.4 kilograms of at least 94%.

A person who intends to engage in the business of manufacturing quasi-drugs shall be equipped with necessary facilities in accordance with the facility standards prescribed by Presidential Decree and file a manufacturing report with the Minister of Food and Drug Administration, obtain marketing approval or file a item report for each item, shall not sell quasi-drugs manufactured under non-sanitary conditions that may cause harm to public health and sanitation, or manufacture, import, store, or display quasi-drugs manufactured at a place that has failed to meet the standards prescribed by Presidential Decree, or shall not include false or misleading matters concerning the relevant quasi-drugs on the containers or packages of quasi-drugs.

From January 2020, the Corrovia viral infection-19 (hereinafter referred to as "cona 19") has spread worldwide, and is used for health.